Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ioanna Sakellari

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
International Journal of Molecular Sciences|June 4, 2020
A New Era in Endothelial Injury Syndromes: Toxicity of CAR-T Cells and the Role of ImmunityEleni Gavriilaki, Ioanna Sakellari, Maria Gavriilaki, et al.
Expert Review of Hematology|August 13, 2021
Endothelial dysfunction and vascular complications after allogeneic hematopoietic cell transplantation: an expert analysisIoannis Eftychidis, Ioanna Sakellari, Achilles Anagnostopoulos, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 25, 2020
The Impact of Antibiotic-Mediated Modification of the Intestinal Microbiome on Outcomes of Allogeneic Hematopoietic Cell Transplantation: Systematic Review and Meta-AnalysisMaria Gavriilaki, Ioanna Sakellari, Achilles Anagnostopoulos, et al.
Pharmaceuticals (Basel, Switzerland)|May 25, 2024
Change in Neurocognitive Function in Patients Who Receive CAR-T Cell Therapies: A Steep Hill to ClimbEvlampia Strongyli, Paschalis Evangelidis, Ioanna Sakellari, et al.
Stem Cells International|July 26, 2019
Autologous Hematopoietic Cell Transplantation in Multiple Sclerosis: Changing Paradigms in the Era of Novel AgentsMaria Gavriilaki, Ioanna Sakellari, Eleni Gavriilaki, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 17, 2019
Early Prediction of Cardiovascular Risk after Hematopoietic Cell Transplantation: Are We There Yet?Eleni Gavriilaki, Eugenia Gkaliagkousi, Ioanna Sakellari, et al.
Journal of Blood Medicine|April 1, 2021
Complement in Sickle Cell Disease: Are We Ready for Prime Time?Christos Varelas, Athina Tampaki, Ioanna Sakellari, et al.
International Journal of Molecular Sciences|March 29, 2023
Molecular Advances in Sinusoidal Obstruction Syndrome/Veno-Occlusive DiseaseIoulia Mavrikou, Dimitrios Chatzidimitriou, Lemonia Skoura, et al.
Cancers|December 23, 2023
Promises and Pitfalls of Next-Generation Treg Adoptive ImmunotherapyPanayiota Christofi, Chrysoula Pantazi, Nikoleta Psatha, et al.
Expert Review of Hematology|January 8, 2026
Treosulfan-based conditioning strategies in older or frail patients undergoing allogeneic hematopoietic cell transplantationPaschalis Evangelidis, Grigorios Salvaras, Anna Vardi, et al.
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
International Journal of Molecular Sciences|June 4, 2020
A New Era in Endothelial Injury Syndromes: Toxicity of CAR-T Cells and the Role of ImmunityEleni Gavriilaki, Ioanna Sakellari, Maria Gavriilaki, et al.
Expert Review of Hematology|August 13, 2021
Endothelial dysfunction and vascular complications after allogeneic hematopoietic cell transplantation: an expert analysisIoannis Eftychidis, Ioanna Sakellari, Achilles Anagnostopoulos, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 25, 2020
The Impact of Antibiotic-Mediated Modification of the Intestinal Microbiome on Outcomes of Allogeneic Hematopoietic Cell Transplantation: Systematic Review and Meta-AnalysisMaria Gavriilaki, Ioanna Sakellari, Achilles Anagnostopoulos, et al.
Pharmaceuticals (Basel, Switzerland)|May 25, 2024
Change in Neurocognitive Function in Patients Who Receive CAR-T Cell Therapies: A Steep Hill to ClimbEvlampia Strongyli, Paschalis Evangelidis, Ioanna Sakellari, et al.
Stem Cells International|July 26, 2019
Autologous Hematopoietic Cell Transplantation in Multiple Sclerosis: Changing Paradigms in the Era of Novel AgentsMaria Gavriilaki, Ioanna Sakellari, Eleni Gavriilaki, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 17, 2019
Early Prediction of Cardiovascular Risk after Hematopoietic Cell Transplantation: Are We There Yet?Eleni Gavriilaki, Eugenia Gkaliagkousi, Ioanna Sakellari, et al.
Journal of Blood Medicine|April 1, 2021
Complement in Sickle Cell Disease: Are We Ready for Prime Time?Christos Varelas, Athina Tampaki, Ioanna Sakellari, et al.
International Journal of Molecular Sciences|March 29, 2023
Molecular Advances in Sinusoidal Obstruction Syndrome/Veno-Occlusive DiseaseIoulia Mavrikou, Dimitrios Chatzidimitriou, Lemonia Skoura, et al.
Cancers|December 23, 2023
Promises and Pitfalls of Next-Generation Treg Adoptive ImmunotherapyPanayiota Christofi, Chrysoula Pantazi, Nikoleta Psatha, et al.
Expert Review of Hematology|January 8, 2026
Treosulfan-based conditioning strategies in older or frail patients undergoing allogeneic hematopoietic cell transplantationPaschalis Evangelidis, Grigorios Salvaras, Anna Vardi, et al.
Pageof 10